26-A-8397-ACC EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL
JACC · 2026-04 · 87 (13) · A166
DOI: 10.1016/j.jacc.2026.02.413 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Beijian Chen und 22 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, B., Pei, Z., HUANG, Z., Zhang, S., Cui, H., Zheng, G., PENG, D., Xu, H., Tang, C., ZHANG, P., Zhang, C., Wu, N., Zhang, P., Zhang, J., Zhou, Y., Zhai, G., Jiang, W., Ling, Z., Hui, X., …, & Huo, Y. (2026). 26-A-8397-ACC EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL. JACC, 87(13), A166. https://doi.org/10.1016/j.jacc.2026.02.413
Vancouver
Chen B, Pei Z, HUANG Z, Zhang S, Cui H, Zheng G, et al. 26-A-8397-ACC EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL. JACC. 2026;87(13):A166. doi:10.1016/j.jacc.2026.02.413
BibTeX
@article{Chen2026,
author = {Chen, Beijian and Pei, Zhaohui and HUANG, ZHOUQING and Zhang, Shu and Cui, Hanbin and Zheng, Guanzhong and PENG, DAOQUAN and Xu, Huipu and Tang, Chengchun and ZHANG, PING and Zhang, Cheng and Wu, Na-Qiong and Zhang, Peidong and Zhang, Jianping and Zhou, Yujie and Zhai, Guangyao and Jiang, Weihong and Ling, Zhiyu and Hui, Xiaogang and Zhang, Lei and Chang, Shuang and Liu, Meng and Huo, Yong},
title = {26-A-8397-ACC EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A166},
doi = {10.1016/j.jacc.2026.02.413}
}
EUVIMED